J. Camdessanché

J. Antoine, J. Camdessanché, F. Cissé, 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[Internet and amyotrophic lateral sclerosis treatment: what is wrong?].

A. Destée, M. Giroud, V. Meininger, 2009, Revue neurologique (Paris).

TNF-α inhibitors used as steroid-sparing maintenance monotherapy in parenchymal CNS sarcoidosis

J. Camdessanché, C. Giannesini, A. Mékinian, 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.

P. Vermersch, M. Giroud, M. Clanet, 2015, Brain : a journal of neurology.

Brain immunohistopathological study in a patient with anti‐NMDAR encephalitis

P. Convers, J. Honnorat, J. Antoine, 2011, European journal of neurology.

Demyelinating polyradiculoneuropathy under combined BRAF/MEK inhibitors.

S. Dalle, J. Camdessanché, P. Devic, 2017, European journal of cancer.

Completing the Immunological Fingerprint by Refractory Proteins: Autoantibody Screening via an Improved Immunoblotting Technique

J. Antoine, J. Camdessanché, C. Moritz, 2019, Proteomics. Clinical applications.

How is neuromuscular fatigability affected by perceived fatigue and disability in people with multiple sclerosis?

G. Millet, S. J. Aboodarda, J. Camdessanché, 2022, Frontiers in neurology.

Prevalence of fatigue and its explicative variables among people with multiple sclerosis.

G. Millet, J. Camdessanché, Nicolas Royer, 2022, NeuroRehabilitation.

End-Plate Disorders in Intensive Care Unit.

J. Camdessanché, J. Camdessanche, 2020, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

Paraneoplastic anti‐CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy

M. Magistris, J. Honnorat, J. Antoine, 2001, Annals of neurology.

Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts

E. Leray, J. Lechner-Scott, M. Onofrj, 2021, CNS Drugs.

Paraneoplastic subacute sensory neuropathy with triple positive antineuronal antibodies associated with small-cell lung cancer

M. Killian, J. Camdessanché, P. Cathébras, 2020, BMJ Case Reports.

Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies

A. Martinez, J. Antoine, J. Camdessanché, 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

Stratégie diagnostique devant une neuronopathie sensitive

J. Antoine, J. Camdessanché, J. Camdessanche, 2014 .

Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders

S. Vukusic, B. Brochet, D. Brassat, 2017, Multiple sclerosis.

COVID-19 may induce Guillain–Barré syndrome

B. Pozzetto, J. Camdessanché, E. Botelho-Nevers, 2020, Revue Neurologique.

Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis

E. Thouvenot, D. Laplaud, J. Camdessanché, 2022, Neurology: Neuroimmunology & Neuroinflammation.

[Paraneoplastic peripheral neuropathies].

J. Antoine, J. Camdessanché, J. Camdessanche, 2014, Revue neurologique.

Paraneoplastic Peripheral Neuropathy Associated With Anti‐hu Antibodies. A Clinical And Electrophysiological Study Of 20 Patients

P. Convers, D. Michel, J. Honnorat, 2002 .

Antifibroblast growth factor receptor 3 antibodies identify a subgroup of patients with sensory neuropathy

J. Honnorat, J. Antoine, J. Camdessanché, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

Testing the validity of a set of diagnostic criteria for sensory neuronopathies: a francophone collaborative study

J. Lefaucheur, J. Pouget, T. Maisonobe, 2014, Journal of Neurology.

Thrombolytic treatment in acute cerebral infarction

J. Camdessanché, J. Camdessanche, 2007 .

Conformation-stabilizing ELISA and cell-based assays reveal patient subgroups targeting three different epitopes of AGO1 antibodies

J. Antoine, J. Camdessanché, C. Moritz, 2022, Frontiers in Immunology.

Spastic paraplegia due to recessive or dominant mutations in ERLIN2 can convert to ALS

M. Amador, G. Stevanin, J. Antoine, 2019, Neurology: Genetics.

Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 BIOPSY-PROVEN patients

D. Maucort-Boulch, J. Dufour, J. Antoine, 2016, Journal of Neurology.

[N-methyl-d-aspartate receptor antibody encephalitis: a treatable disorder involving B-lymphocytes. A report of two patients].

J. Antoine, J. Camdessanché, Fabien Forest, 2012, La Revue de medecine interne.

Acute hemorrhagic leukoencephalopathy associated with influenza A (H1N1) virus

J. Antoine, J. Camdessanché, S. Pillet, 2011, Journal of Neurology.

Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study

E. Leray, S. Vukusic, E. Thouvenot, 2022, The Lancet regional health. Europe.

Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study

P. Cintas, P. Corcia, P. Couratier, 2008, European journal of neurology.

[Paraneoplastic neurological syndromes].

J. Antoine, J. Camdessanché, J. Camdessanche, 2007, Presse medicale.

Neurologic manifestations associated with COVID-19: a multicentre registry

L. Defebvre, G. Béraud, G. Edan, 2020, Clinical Microbiology and Infection.

Reducing the risk of misdiagnosis of indirect ELISA by normalizing serum-specific background noise: The example of detecting anti-FGFR3 autoantibodies.

J. Antoine, J. Camdessanché, C. Moritz, 2019, Journal of immunological methods.

Assessment of implicit language and theory of mind in multiple sclerosis.

B. Laurent, C. Borg, J. Camdessanché, 2020, Annals of physical and rehabilitation medicine.

A Genome-Scale DNA Repair RNAi Screen Identifies SPG48 as a Novel Gene Associated with Hereditary Spastic Paraplegia

A. Shevchenko, A. Durr, I. Poser, 2010, PLoS biology.

Added value of electromyography in the diagnosis of myopathy: A consensus exercise

A. Fuglsang-Frederiksen, M. Carvalho, I. Schofield, 2017, Clinical Neurophysiology.

Dural localization of extramedullary hematopoiesis. Report of a case

J. Antoine, J. Camdessanché, R. Mohammedi, 2009, Journal of Neurology.

Disability progression in multiple sclerosis patients using early first‐line treatments

E. Leray, S. Vukusic, E. Thouvenot, 2022, European journal of neurology.

Autoantigenomics: Holistic characterization of autoantigen repertoires for a better understanding of autoimmune diseases.

Stéphane Paul, Christian P Moritz, Oda Stoevesandt, 2019, Autoimmunity reviews.

Vincristine‐induced neuropathy: Atypical electrophysiological patterns in children

Y. Péréon, L. Leclair-Visonneau, A. Magot, 2015, Muscle & nerve.

The pattern and diagnostic criteria of sensory neuronopathy: a case–control study

J. Honnorat, J. Antoine, P. Petiot, 2009, Brain : a journal of neurology.

Usefulness and prognostic value of diagnostic tests in patients with possible chronic inflammatory demyelinating polyradiculoneuropathy

P. Convers, S. Rheims, J. Antoine, 2022, Muscle & nerve.

Prognostic Factors and Treatment Efficacy in Spinal Cord Sarcoidosis

J. Dufour, B. Bonnotte, J. Antoine, 2022, Neurology.

Pregnancy and myopathies: Reciprocal impacts between pregnancy, delivery, and myopathies and their treatments. A clinical review.

L. Féasson, J. Camdessanché, B. Zagorda, 2021, Revue neurologique.

A clinical pattern‐based etiological diagnostic strategy for sensory neuronopathies: a French collaborative study

J. Pouget, T. Maisonobe, J. Antoine, 2012, Journal of the peripheral nervous system : JPNS.

Impact of a frequent nearsplice SOD1 variant in amyotrophic lateral sclerosis: optimising SOD1 genetic screening for gene therapy opportunities

Y. Marie, V. Meininger, F. Salachas, 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

Acute camptocormia induced by olanzapine: a case report

J. Camdessanché, M. Koenig, F. Robert, 2010, Journal of medical case reports.

Brain hemorrhage as a complication of type I cryoglobulinemia vasculopathy

L. Mazzola, F. Barral, D. Michel, 2003, Journal of Neurology.

Identifying a therapeutic window in acute and subacute inflammatory sensory neuronopathies

J. Lefaucheur, J. Pouget, T. Maisonobe, 2016, Journal of the Neurological Sciences.

Proposition de critères diagnostiques de neuronopathie sensitive

J. Antoine, J. Camdessanché, C. Vial, 2009 .

Solitary fibrous tumors of the central nervous system: report of five cases with unusual clinicopathological and outcome patterns

F. Vassal, C. Nuti, M. Péoc'h, 2011, Acta Neurochirurgica.

Prognostic Factors and Treatments Efficacy in Spinal Cord Sarcoidosis: An Observational Cohort With Long-term Follow-up.

J. Dufour, B. Bonnotte, J. Antoine, 2022, Neurology.

Acute neurological worsening after Rituximab treatment in patients with anti-MAG neuropathy

J. Antoine, J. Camdessanché, Emilie Sala, 2014, Journal of the Neurological Sciences.

Absence of Airway Secretion Accumulation Predicts Tolerance of Noninvasive Ventilation in Subjects With Amyotrophic Lateral Sclerosis

E. Broussolle, I. Court-Fortune, J. Antoine, 2013, Respiratory Care.

Current clinical management of CIDP with immunoglobulins in France: An expert opinion.

Y. Péréon, P. Cintas, M. Michaud, 2023, Revue neurologique.

Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference

S. Vukusic, E. Thouvenot, P. Cabre, 2022, Neurology.

Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome

P. Vermersch, C. Louapre, S. Vukusic, 2021, JAMA network open.

The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies.

E. Leray, J. Lechner-Scott, M. Onofrj, 2021, Multiple sclerosis and related disorders.

Diagnostic criteria for amyotrophic lateral sclerosis: A multicentre study of inter-rater variation and sensitivity

M. Swash, M. de Carvalho, A. Fuglsang-Frederiksen, 2019, Clinical Neurophysiology.

Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study

E. Leray, M. Clanet, S. Vukusic, 2015, PloS one.

Mutation in the RRM2 domain of TDP-43 in Amyotrophic Lateral Sclerosis with rapid progression associated with ubiquitin positive aggregates in cultured motor neurons

P. Vourc'h, C. Andres, P. Corcia, 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[Update on fundamental and clinical research in amyotrophic lateral sclerosis].

A. Echaniz-Laguna, P. Cintas, P. Corcia, 2009, Revue neurologique.

CLIPPERS and its mimics: evaluation of new criteria for the diagnosis of CLIPPERS

K. Hoang-Xuan, À. Rovira, N. Téllez, 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

Progress in hereditary neuropathies, myopathies and motoneuron disorders!

P. Laforêt, J. Camdessanché, J. Camdessanche, 2023, Revue neurologique.

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis

P. Vermersch, E. Leray, S. Vukusic, 2019, Neurology.

Value of TENS for relief of chronic low back pain with or without radicular pain

B. Laurent, J. Camdessanché, M. Lanteri-Minet, 2012, European journal of pain.

Effect of familial clustering in the genetic screening of 235 French ALS families

V. Meininger, F. Salachas, F. Viader, 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

Brain plasticity in the motor network is correlated with disease progression in amyotrophic lateral sclerosis

F. Schneider, I. Faillenot, J. Antoine, 2013, Human brain mapping.

Unclear association between COVID-19 and Guillain-Barré syndrome

G. Gigli, J. Honnorat, J. Antoine, 2021, Brain : a journal of neurology.

[Extrapontine myelinolysis of favorable outcome in a patient with autoimmune polyglandular syndrome].

J. Antoine, J. Camdessanché, M. Koenig, 2005, La Revue de medecine interne.

Peripheral small fiber dysfunction and neuropathic pain in patients with Morvan syndrome

F. Ducray, F. Mauguière, S. Vukusic, 2015, Neurology.

Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal

E. Leray, S. Vukusic, E. Thouvenot, 2022, Neurotherapeutics.